E
ExpreS2ion Biotech Holding AB
F:5JD
ExpreS2ion Biotech Holding AB
F:5JD
Price:
1.8
EUR
-5.26%
Market Cap:
€200.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
E
|
ExpreS2ion Biotech Holding AB
F:5JD
|
SE |
|
C
|
City of London Investment Group PLC
OTC:CLIUF
|
UK |
|
Befesa SA
F:BFSA
|
LU |
|
A
|
Ashoka Buildcon Ltd
BSE:533271
|
IN |
|
A
|
Amyris Inc
SWB:3A01
|
US |
|
A
|
Arrow Electronics Inc
F:ARW
|
US |
|
C
|
Capgemini SE
XBER:CGM
|
FR |
|
A
|
Aviat Networks Inc
F:HSD1
|
US |
Price Target
Loading...
Revenue
Loading...
Gross Profit
Loading...
Operating Income
Loading...
Pre-Tax Income
Loading...
Net Income
Loading...
Wall St Price Targets
5JD Price Targets Summary
ExpreS2ion Biotech Holding AB
ExpreS2ion Biotech Holding AB
Wall Street analysts forecast 5JD stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 5JD is 6.86 EUR with a low forecast of 6.8 EUR and a high forecast of 7.07 EUR.
Lowest Forecast
Price Target
6.8
EUR
278% Upside
Average Forecast
Price Target
6.86
EUR
281% Upside
Highest Forecast
Price Target
7.07
EUR
293% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 5JD's stock price target?
Price Target
6.86
EUR
6.86
EUR
According to Wall Street analysts, the average 1-year price target for 5JD is 6.86 EUR with a low forecast of 6.8 EUR and a high forecast of 7.07 EUR.
What is the Revenue forecast for ExpreS2ion Biotech Holding AB?
Projected CAGR
39%
39%
The compound annual growth rate for Revenue over the next 3 years is 39%.
